GlassScriptPhysician profile
Kimberly Lee Evans
NPI 1962587337
$1,483.16
in general payments reported to CMS, 2019-2025
14 companies · $486 in 2025
The $486 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $27.11 · 2021: $176 · 2022: $340 · 2023: $245 · 2024: $37.64 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $769.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $768.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $485.78 | 2025 | Daxxify |
| Merz North America, INC. | $271.94 | 2022 | |
| Abbvie INC. | $260.94 | 2021-2023 | |
| Galderma Laboratories, L.P. | $118.46 | 2019 | |
| Sanofi-Aventis U.S. LLC | $98.90 | 2023 | |
| Pfizer INC. | $79.01 | 2019-2024 | |
| Allergan, INC. | $32.94 | 2020-2022 | |
| Mylan Pharmaceuticals INC. | $22.23 | 2021 | |
| Hologic Sales and Service, LLC | $22.21 | 2019 | |
| Exeltis, USA INC. | $21.67 | 2021 | |
| Astellas Pharma US INC | $20.99 | 2022 | |
| Acella Pharmaceuticals, LLC | $20.97 | 2024 | NP Thyroid 60 |
| Ibsa Pharma INC. | $15.30 | 2022 | |
| Acessa Health INC. | $11.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.